Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qing'ao Granules
- Development stage
- Unknown
- Lead developer
- Liangshan Prefecture Hospital of Traditional Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Qing'ao Granules is a Traditional Chinese Medicine (TCM) formulation developed as an in-hospital preparation by the Liangshan Prefecture Hospital of Traditional Chinese Medicine. It is primarily indicated for the treatment of chronic hepatitis B (CHB). The granules are used as an adjunctive therapy to enhance the efficacy of standard antiviral regimens, such as peginterferon α-2b and nucleos(t)ide analogues (NAs), particularly in patients who have achieved HBV DNA negativity but still carry low levels of HBsAg. The clinical objective of adding Qing'ao Granules is to promote HBsAg seroconversion and achieve a functional cure. As a botanical-based therapy, its pharmacological profile likely involves the modulation of the host immune response and protection of hepatic function.
- Brand names
- Qing'ao Granules
- Other names
- Qing'ao Keli青奥颗粒
Beyond the preview
Go deeper on Qing'ao Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qing'ao Granules.